Senti Biosciences is trading at $0.36, up +5.48%, on September 4, 2026, after announcing $4.5 million in financing.

  • The package includes a completed $2.0 million senior secured convertible-note sale.
  • Celadon Partners’ affiliate committed $2.5 million in new equity financing.
  • The financing follows earlier Celadon-related convertible-note activity; the broader market is mixed.